Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 24.07 | 12.19 | 26.97 | - |
Short Term Investments | 76.68 | 73.99 | 77.02 | 0.00 |
Cashand Short Term Investments | 100.74 | 98.99 | 160.29 | 0.25 |
Accounts Receivable- Trade Net | 519.34 | 440.05 | 376.66 | 0.00 |
Total Receivables Net | 589.31 | 452.40 | 388.21 | 0.00 |
Total Inventory | 649.44 | 602.04 | 475.45 | 0.00 |
Prepaid Expenses | 6.15 | 2.32 | 4.20 | - |
Other Current Assets Total | 0.00 | - | - | 0.00 |
Total Current Assets | 1,345.64 | 1,155.76 | 1,028.15 | 0.25 |
Property/ Plant/ Equipment Total- Gross | 1,630.04 | 1,453.65 | 1,350.42 | - |
Accumulated Depreciation Total | -536.85 | -467.57 | -405.11 | - |
Property/ Plant/ Equipment Total- Net | 1,093.19 | 986.08 | 945.31 | 0.00 |
Goodwill Net | 1.78 | 1.78 | 1.78 | 0.00 |
Intangibles Net | 75.27 | 39.85 | 22.37 | 0.00 |
Long Term Investments | 36.78 | 35.52 | 32.23 | 0.00 |
Note Receivable- Long Term | 18.11 | 2.49 | 1.48 | - |
Other Long Term Assets Total | 11.33 | 9.44 | 8.58 | 0.00 |
Total Assets | 2,582.11 | 2,230.93 | 2,039.90 | 0.25 |
Accounts Payable | 378.32 | 346.76 | 214.59 | 0.00 |
Accrued Expenses | 15.26 | 13.04 | - | - |
Notes Payable/ Short Term Debt | 264.06 | 213.78 | 337.73 | 0.02 |
Current Portof LT Debt/ Capital Leases | 4.49 | 0.82 | 1.59 | - |
Other Currentliabilities Total | 32.26 | 17.17 | 26.76 | 0.00 |
Total Current Liabilities | 694.39 | 591.57 | 580.66 | 0.02 |
Capital Lease Obligations | 16.70 | 0.72 | 2.08 | 0.00 |
Total Long Term Debt | 16.70 | 0.72 | 2.08 | 0.00 |
Total Debt | 285.25 | 215.31 | 341.40 | 0.02 |
Deferred Income Tax | 107.92 | 78.84 | 70.67 | 0.00 |
Other Liabilities Total | 6.06 | 1.32 | 0.00 | 0.00 |
Total Liabilities | 825.07 | 672.44 | 653.42 | 0.02 |
Common Stock Total | 45.31 | 45.31 | 0.25 | 0.25 |
Additional Paid- In Capital | 440.33 | 440.33 | 440.33 | - |
Retained Earnings( Accumulated Deficit) | 1,263.34 | 1,064.33 | 890.03 | - |
Other Equity Total | 8.06 | 8.52 | 55.88 | -0.02 |
Total Equity | 1,757.04 | 1,558.49 | 1,386.48 | 0.23 |
Total Liabilities Shareholders' Equity | 2,582.11 | 2,230.93 | 2,039.90 | 0.25 |
Total Common Shares Outstanding | 9.06 | 9.06 | 9.06 | 9.06 |
Tangible Book Valueper Share Common Eq | 185.38 | 167.38 | 150.32 | 0.03 |
Cash Equivalents | - | 12.81 | 56.31 | 0.25 |
Long Term Debt | - | - | - | 0.00 |
Aarti Pharmalabs Dividend Aarti Pharmalabs Bonus Aarti Pharmalabs News Aarti Pharmalabs AGM Aarti Pharmalabs Rights Aarti Pharmalabs Splits Aarti Pharmalabs Board Meetings Aarti Pharmalabs Key Metrics Aarti Pharmalabs Shareholdings Aarti Pharmalabs Profit Loss Aarti Pharmalabs Cashflow Aarti Pharmalabs Q1 Results Aarti Pharmalabs Q2 Results Aarti Pharmalabs Q3 Results Aarti Pharmalabs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks